The age- and amyloid-β-related increases in Nogo B contribute to microglial activation

[1]  M. Schwab,et al.  Role of Nogo-A in Neuronal Survival in the Reperfused Ischemic Brain , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  T. Woodruff,et al.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. , 2010, Brain : a journal of neurology.

[3]  S. Maier,et al.  Sustained hippocampal IL-1β overexpression impairs contextual and spatial memory in transgenic mice , 2010, Brain, Behavior, and Immunity.

[4]  M. Lynch,et al.  A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL , 2010, Neurobiology of Aging.

[5]  M. O’Banion,et al.  Sustained expression of interleukin-1β in mouse hippocampus impairs spatial memory , 2009, Neuroscience.

[6]  Y. Suárez,et al.  Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair , 2009, Proceedings of the National Academy of Sciences.

[7]  A. Pitkänen,et al.  Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice , 2009, Neuroscience.

[8]  M. Lynch,et al.  Fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway attentuates microglial activation in vivo and in vitro , 2009, Journal of neurochemistry.

[9]  Marina A. Lynch,et al.  The Multifaceted Profile of Activated Microglia , 2009, Molecular Neurobiology.

[10]  M. Lynch,et al.  Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain , 2009, Neurobiology of Aging.

[11]  M. Lynch,et al.  The deficit in long-term potentiation induced by chronic administration of amyloid-β is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025 , 2009, Experimental Gerontology.

[12]  J. Bloch,et al.  Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates – re-examination and extension of behavioral data , 2009, The European journal of neuroscience.

[13]  M. Lynch,et al.  Neuroinflammatory changes increase the impact of stressors on neuronal function. , 2009, Biochemical Society transactions.

[14]  Y. Suh,et al.  Minocycline and neurodegenerative diseases , 2009, Behavioural Brain Research.

[15]  L. Xiong,et al.  Trans-activator of Transcription-mediated Delivery of NEP1-40 Protein into Brain Has a Neuroprotective Effect against Focal Cerebral Ischemic Injury via Inhibition of Neuronal Apoptosis , 2008, Anesthesiology.

[16]  S. David,et al.  Novel roles for Nogo receptor in inflammation and disease , 2008, Trends in Neurosciences.

[17]  M. Lynch,et al.  A Pivotal Role for Interleukin-4 in Atorvastatin-associated Neuroprotection in Rat Brain* , 2008, Journal of Biological Chemistry.

[18]  M. Lynch,et al.  Modulation of amyloid‐β‐induced and age‐associated changes in rat hippocampus by eicosapentaenoic acid , 2007, Journal of neurochemistry.

[19]  H. Thompson,et al.  Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. , 2007, Journal of neurosurgery.

[20]  Dana Kilroy,et al.  Eicosapentaenoic acid confers neuroprotection in the amyloid-β challenged aged hippocampus , 2007, Neurobiology of Aging.

[21]  M. Lynch,et al.  IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro , 2007, Journal of neurochemistry.

[22]  M. Lynch,et al.  The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-β1–42 in the rat hippocampus in vivo , 2007, Neuropharmacology.

[23]  M. Lynch,et al.  The age‐related attenuation in long‐term potentiation is associated with microglial activation , 2006, Journal of neurochemistry.

[24]  G. Lynch,et al.  Synaptic plasticity in early aging , 2006, Ageing Research Reviews.

[25]  Tingting Zou,et al.  ER stress triggers apoptosis induced by Nogo-B/ASY overexpression. , 2006, Experimental cell research.

[26]  Xiaoping Zhou,et al.  Reticulon proteins: emerging players in neurodegenerative diseases , 2006, Cellular and Molecular Life Sciences CMLS.

[27]  J. Julien,et al.  Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.

[28]  S. Strittmatter,et al.  Alzheimer Precursor Protein Interaction with the Nogo-66 Receptor Reduces Amyloid-β Plaque Deposition , 2006, The Journal of Neuroscience.

[29]  Y. Qi,et al.  ER Ca2+ depletion triggers apoptotic signals for endoplasmic reticulum (ER) overload response induced by overexpressed reticulon 3 (RTN3/HAP) , 2005, Journal of cellular physiology.

[30]  M. Lynch,et al.  Role of Interleukin-4 in Regulation of Age-related Inflammatory Changes in the Hippocampus* , 2005, Journal of Biological Chemistry.

[31]  Eric Klann,et al.  Reactive oxygen species and synaptic plasticity in the aging hippocampus , 2004, Ageing Research Reviews.

[32]  P. Garnier,et al.  Hypoxia induces caspase‐9 and caspase‐3 activation without neuronal death in gerbil brains , 2004, The European journal of neuroscience.

[33]  B. Tang,et al.  Inter‐ and intracellular interactions of Nogo: new findings and hypothesis , 2004, Journal of neurochemistry.

[34]  S. Strittmatter,et al.  A new role for Nogo as a regulator of vascular remodeling , 2004, Nature Medicine.

[35]  J. Steeves,et al.  Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[36]  M. Schwab,et al.  Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure 1 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  M. Schwab,et al.  Do cancer cells die because of Nogo-B? , 2003, Oncogene.

[38]  M. Schwab,et al.  Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. , 2003, Journal of molecular biology.

[39]  S. Strittmatter,et al.  Localization of Nogo-A and Nogo-66 Receptor Proteins at Sites of Axon–Myelin and Synaptic Contact , 2002, The Journal of Neuroscience.

[40]  M. Schwab,et al.  Patterns of Nogo mRNA and Protein Expression in the Developing and Adult Rat and After CNS Lesions , 2002, The Journal of Neuroscience.

[41]  G. M. Cole,et al.  Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology , 2001, Neurobiology of Aging.

[42]  C. Spenger,et al.  NOGO mRNA Expression in Adult and Fetal Human and Rat Nervous Tissue and in Weight Drop Injury , 2001, Experimental Neurology.

[43]  M. Takeda,et al.  A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity , 2000, Oncogene.

[44]  S. Strittmatter,et al.  Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein , 2000, Nature.

[45]  Martin E. Schwab,et al.  Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 , 2000, Nature.

[46]  R. Prinjha,et al.  Neurobiology: Inhibitor of neurite outgrowth in humans , 2000, Nature.

[47]  G. Lienhard,et al.  Cloning and characterization of a 22 kDa protein from rat adipocytes: a new member of the reticulon family. , 1999, Biochimica et biophysica acta.

[48]  C. Barnes,et al.  Neural plasticity in the ageing brain , 2006, Nature Reviews Neuroscience.

[49]  M. Lynch,et al.  Long-term potentiation and memory. , 2004, Physiological reviews.